Outcomes Summary for Nandrolone

The available evidence on nandrolone outcomes is limited and primarily derived from small clinical trials and preclinical studies. The strength of evidence is weak to moderate at best, with most human studies being early-phase trials with limited sample sizes.

Clinical Outcomes

Sarcopenia Treatment: One phase 2 trial (NCT05978206) is currently recruiting participants to evaluate nandrolone's effectiveness in treating sarcopenia when combined with physiotherapy and dietary interventions. Results are not yet available.

Telomeropathies: A completed phase 1/2 trial (NCT02055456) investigated nandrolone decanoate for treating telomeropathies, though specific outcomes data from this study are not provided in the available evidence.

Cancer-Related Malnutrition: One completed study (NCT03263520) examined nandrolone's impact on cancer-induced malnutrition, but outcome measures and results are not detailed in the available evidence.

Preclinical Findings

Animal studies suggest several concerning effects:

Liver toxicity: Research in rats indicates nandrolone decanoate can cause liver injury, though protective effects of certain compounds (cumin oil) have been investigated
Reproductive effects: Studies in male mice show that prepubertal nandrolone exposure can alter testicular structure and spermatogenic function
Neurological effects: In previously untrained male mice, supraphysiological androgen doses (including nandrolone-related compounds) did not provide additional benefits for hippocampal plasticity markers or behavior

Evidence Limitations

The current evidence base has significant limitations:

Most human trials are early-phase with no published outcome data available
Sample sizes appear small based on trial descriptions
Long-term safety and efficacy data are lacking
Most available research focuses on adverse effects rather than therapeutic benefits

Disclaimer: This summary is for informational purposes only and should not be considered medical advice. Any decisions regarding nandrolone use should be made in consultation with qualified healthcare professionals who can evaluate individual circumstances and current clinical evidence.

The evidence suggests potential therapeutic applications for nandrolone in specific conditions, but robust clinical data supporting its efficacy and safety profile remain limited.

Nandrolone

Member access required